High sensitivity cardiac troponin (hscTn) assays are being implemented worldwide. This session will use
case studies to prepare users for the anticipated increases in abnormal troponin findings. Three 40-
minute case presentations will address the analytical and clinical challenges affecting both primary and secondary prevention of cardiac damage, as well as acute and chronic care of cardiac patients. A question and answer period will follow the three case presentations.